Compare S&P Global Inc (SPGI) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

S&P Global IncTrade

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

S&P Global Inc vs State Street SPDR S&P Biotech ETF — how do they compare? S&P Global Inc trades at $431.27 (market cap $132.71B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: S&P Global Inc pays a 0.87% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, S&P Global Inc nearer its low. Which is the better fit depends on your goals.

	SPGI	XBI
Market Cap	$132.71B	—
Sector	Financials	Broad Market / Factor
52-Week High	$534.79	$164.28
52-Week Low	$370.42	$85.16
Enterprise Value	$144.68B	—
Dividend Yield	0.87%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SPGI

S&P Dow Jones and Pantera launch a new digital asset index focused on quality and real utility.PRNewsWire · 8 hours agoBullish S&P Global launches AI Data Portal with dual data retrieval methods for flexible AI access.PRNewsWire · 9 hours agoBullish S&P DJI and MSCI launch consultation on potential updates to GICS industry classification system.PRNewsWire · 4 days agoNeutral View details →

XBI

Healthcare ETFs lead State Street's top 5 performers with pharma fund gaining 11.7% in the past monthETF Trends · 4 days agoBullish View details →

About S&P Global Inc

S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.